IAS
UTHR icon

IMA Advisory Services’s United Therapeutics UTHR Stock Holding History

IMA Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96K Buy
11
+4
+57% +$2.25K ﹤0.01% 866
2026
Q1 		$4.15K Hold
7
– – ﹤0.01% 450
2025
Q4 		$3.41K Buy
+7
New +$3.26K ﹤0.01% 522

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

IMA Advisory Services's UTHR Position: Q2 2026 in Review

IMA Advisory Services increased its United Therapeutics (UTHR) stake by 57% in Q2 2026, buying an estimated $2.25K and bringing the position to 11 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

IMA Advisory Services first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • IMA Advisory Services held 11 shares of United Therapeutics worth $5.96K as of Q2 2026.
  • IMA Advisory Services bought 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
  • United Therapeutics made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #866 holding.
  • IMA Advisory Services first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.